Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Monkey Pox Treatment Market?

There has been a swift expansion in the market size for monkey pox treatment in the past few years. The market is expected to soar up from $0.09 billion in 2024 to $0.1 billion in 2025, showing a compound annual growth rate (CAGR) of 12.6%. This surge during the historical period can be attributed to several factors such as rampant outbreaks in endemic regions, increased awareness about zoonotic transmission, the legacy of smallpox eradication, public health campaigns, and the emergence of human cases.

Rapid expansion is anticipated in the monkey pox treatment market size within the upcoming years, with expectations of reaching a value of $0.16 billion in 2029 and a compound annual growth rate (CAGR) of 13.0%. This growth prospect for the forecast period is linked to factors such as globalization and increased travel, government funding and backing, investments in biotech and pharmaceuticals, public health tracking, and regulatory approvals. The key trends likely to dominate this forecast period are the development of antiviral medicines, the utilization of smallpox vaccines, monoclonal antibodies, combination therapeutic options, and research into long-term immunity.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18818&type=smp

What Growth-Enabling Forces Are Impacting The Monkey Pox Treatment Market?

The escalating occurrences of zoonotic infection are anticipated to boost the expansion of the monkeypox treatment market in future. A zoonotic infection denotes a disease transferred from animals to people through either direct interaction with infected environments or carriers. Enhanced interaction between humans and animals by bringing them closer increases the risks of zoonotic infections. Furthermore, the gravity of this risk is exacerbated by climate change as it broadens the range of disease carriers and introduces pathogens to new territories. Monkeypox treatments are employed to administer zoonotic mpox by aiming at the virus and reducing symptoms in both human beings and possibly infected animals. As an example, a report put forth by the UK Health Security Agency, a government organization based in the UK, showed that in August 2024 there have been 3,732 verified mpox cases in the UK. This represented an increase of 21 more instances from 2023 which had 3,753 cases. Consequently, the growing ubiquity of zoonotic infection propels the monkeypox treatment market.

How Does The Monkey Pox Treatment Market Differ By Segment?

The monkey pox treatmentmarket covered in this report is segmented –

1) By Treatment Type: Prophylactic Vaccines; Therapeutics

2) By Dosage Forms: Solid; Liquid; Semi Solid

3) By Route Of Administration: Oral; Topical; Parenteral

4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies

Subsegments:

1) By Prophylactic Vaccines: Vaccinia-Based Vaccines; Modified Vaccinia Ankara (MVA) Vaccines; Other Vaccines (Recombinant Vaccines)

2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir); Immune Modulators; Supportive Care Treatments

How Are Global Trends Impacting The Development Of The Monkey Pox Treatment Market?

Major firms active in the monkeypox treatment market are concentrating on remote tracking and teletherapy services such as virtual care to boost availability, simplify patient management, and elevate overall treatment results. Virtual care in treating monkeypox offers distant medical consultations, assessing symptoms, and handling strategies to those in danger or already infected; this encourages access to medical services while eliminating the need for physical appointments. For instance, an American healthcare company, Folx Health, premiered ‘Monkeypox Care’ – a virtual primary health services for individuals susceptible or affected by monkeypox, in August 2022. The plan encompasses education, counselling, evaluating symptoms, and providing referrals and is specifically suited to reach people in healthcare deserts – regions with scarce access to healthcare facilities, guaranteeing that high-quality information and reference services are available to everyone, unbiased of geolocation.

Who Are The Most Influential Companies In The Monkey Pox Treatment Market?

Major companies operating in the monkey pox treatment market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

Which Region Is Leading Innovation In The Monkey Pox Treatment Market?

North America was the largest region in the monkey pox treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=18818&type=smp

Browse Through More Reports Similar to the Global Monkey Pox Treatment Market 2025, By The Business Research Company

Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Infection Control Supplies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Infection Prevention Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model